THE purpose of this study is to assess the role of nitric oxide (NO) in the intestinal lesions of passive anaphylax is, since this ex perimental model resembles necrotizing enterocolitis. SpragueDawley rats were sensitized with IgE anti-dinitrophenol monoclonal antibody. Extravasation of protein-rich plasma and haemorrhagia were measured in the small intestine. Plasma histamine was measured to assess mast cell activation. The effect of ex ogenous NO on the lesions was assessed by using two structurally unrelated NOdonors: sodium nitroprusside and S-nitroso-Nacetyl-penicillamine (SNAP). An increased basal production of NO was observed in cells taken after anaphylax is, associated with a reduced response to platelet-activating factor, interleukin 1b, and IgE/DNP-bovine serum albumin complex es. The response to bacterial lipopolysaccharide and dibutyryl cyclic adenosine monophosphate (AMP) was enhanced 24 h after challenge, but at earlier times was not signi cantly different from that observed in controls. Treatment with either sodium nitroprusside or SNAP produced a signicant reduction of the haemorrhagic lesions, which are a hallmark of rat anaphylax is. The ex travasation of protein-rich plasma was not inuenced by NO-donors. The increase of plasma histamine elicited by the anaphylactic challenge was not in uenced by SNAP treatment. NO-donors protect intestinal haemorrhagic lesions of rat anaphylax is by a mechanism apparently independent of mast cell histamine release.
Introduction
Necrosis of the small intestine similar to that produced by endotoxin, tumour necrosis factor 1 or platelet-activating factor 2 is a feature characteristic of rat anaphylaxis, 3, 4 its pathogenetic mechanism being a direct consequence of triggering the cascade of chemical mediators from mast cells by IgE-dependent mechanisms. This necrosis is histologically identical to that seen in neonatal necrotizing enterocolitis. In a previous study we have shown that plateletactivating factor (PAF) is a major effector of this response. Interestingly, the haemorrhagic lesions were dependent on different chemical mediators than those involved in the production of protein-rich plasma extravasation. 5 Nitric oxide (NO) plays an important role in cell signalling (for review see Ref. 6 ) and it has been found in a number of cells that are either directly or indirectly activated in anaphylactic reactions. In addition, NO mediates in ammatory responses and defence mechanisms including killing of microorganisms, oedema and apoptosis. The analysis of the actual role of NO in immunoin ammatory reactions is a matter of debate since it has been reported to produce either tissue injury 7 9 or attenuation of the damage induced by other agents. 10 12 NO affects the function of immune cells by different mechanisms, e.g. interaction with guanylyl cyclase or interference with the transcription factor NF-kB, which among many other functions is the main regulator of the molecules that are involved in the production of endothelial cell activation. 13, 14 The effect of NO as a mediator of gastrointestinal mucosal defence is currently associated with its action as an endogenous scavenger of various free radical species, and there is convincing evidence that administration of large amounts of NO does not cause detectable damage to the mucosa or vasculature of the intestine. 15 Since there is a host of signals that may lead to the production of NO, analysis of the mechanism involved in NO production during anaphylactic reactions should consider a number of alternatives. Thus, release of NO by rat serosal mast cells has been reported. 16 Macrophages are another source of NO and a number of autacoids released from mast cells could potentially lead to the induction of NO production by macrophages, e.g. PAF 17 and tumour necrosis factor-alpha (TNF-a). 18 Moreover, it has been recently reported that IgE-dependent activation of macrophages via FceRII CD23 (low af nity receptor for the Fc portion of IgE) leads to a strong induction of NO production in both rat 19 and human macrophages 20 that allows killing of parasites. In keeping with these data, induction of the inducible isoform of NO synthase during anaphylaxis might occur via either direct or indirect IgE-dependent mechanisms. Even though NO is produced during anaphylactic challenge, its main role in the process may be dif cult to understand in view of both its pleiotropic effects and different timeframes in which it is generated. In this study we have addressed: (1) the effect of IgE-dependent anaphylaxis on the generation of NO by rat peritoneal macrophages; (2) the effect of NOgenerating compounds on the necrotic lesions of the small intestine produced in IgE-dependent reactions; (3) the effect of NO donors on histamine release in IgE-dependent anaphylaxis.
Materials and Methods

Materials and drugs
Monoclonal anti-dinitrophenol (DNP) IgE was obtained from a secreting hybridoma 21 grown as ascites tumours in BALB c mice and puri ed by ammonium sulphate precipitation as described. 4 The amount of speci c antibody was calculated from classical precipitation reactions using antigen and several dilutions of the antibody solution. 22 Dinitrophenol-bovine serum albumin (BSA) containing 8 mol of DNP per mol of BSA was prepared according to the method of Eisen.
23 IgE-DNP-BSA immune complexes at equivalence were made by overnight incubation at 48 C of antigen and the antibody solution followed by extensive washing. 22 1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF), 4b-phorbol 12b-myristate 13a-acetate (PMA), S-nitroso-N-acetyl-penicillamine (SNAP), N-acetyl-DL-penicillamine, and N G -methyl-arginine (L-NMA) were from Sigma Chemical Company, St Louis, MO. Sodium nitroprusside (SNP) was from Fides Laboratories, Spain. TNF-a and interleukin 1b were from Genzyme Corp., Cambridge, MA.
In vivo experimental design
Male Sprague-Dawley rats of about 200 g body weight were passively sensitized with IgE monoclonal antibody (i.p., in 0.2 ml of a phosphatebuffered isotonic saline solution, pH 7.4) at the dose of 12 mg protein kg measured by the method of Bradford. 24 Anaphylactic challenge was performed by i.v. injection with 0.7 mg kg DNP-BSA together with 20 mg kg Evans blue dye (EB) in phosphate-buffered isotonic saline solution to assay protein-rich plasma extravasation (see below) 18 h after sensitization. 25 The experimental protocol was approved by our Institutional Review Board.
Assay of NO production by peritoneal macrophages ex vivo Peritoneal cells were collected in 50 ml of Dulbecco's modi ed Eagle medium (DMEM) without phenol red, pelleted and resuspended in the same medium supplemented with 100 U ml penicillin, 100 mg ml streptomycin, 50 mg ml gentamicin, 0.5 mM L-arginine, 2 mM glutamine and 10% heat-inactivated fetal calf serum. Non-adherent cells were removed by washing after 2 h of incubation, and the production of NO was assessed after incubation at 378 C in an atmosphere containing 5% CO 2 . More than 95% of the adherent cells were macrophages as assessed by both their morphological appearance and functional ability to engulf non-opsonized zymosan particles. Mast cells were , 0 5% of total adherent cells as judged from staining with toluidine blue solution at pH 3.5.
Determination of NO and nitrite
NO released from macrophage cultures was determined by the accumulation of nitrite. 26 The cell cultures (5 3 10 5 in 1 ml of phenol red-free medium) were lled with 100 ml of a solution of 1 mM sulphanilic acid and 100 mM HCl ( nal concentration). After incubation for 5 min the medium was aspirated and centrifuged in an Eppendorf microcentrifuge. Fifty ml of naphthylenediamine (1 mM in the assay) were added to the samples, and the reaction was completed after 15 min of incubation. The absorbance at 548 nm was compared with a standard of NaNO 2 , and the production of NO was expressed as nmol of NO 2 mg protein.
Evaluation of protein-rich plasma extravasation
Vascular permeability changes were evaluated by the EB extravasation method, as described by Jancar et al. 27 The EB was injected into the jugular vein together with the antigen. The jejunum-ileum was dissected, weighed, and put in formamide (4 ml g wet tissue at 208 C for 24 h) to extract the EB. The concentration of EB was determined by spectrophotometry at a wavelength of 620 nm. The results were plotted on a standard curve of EB, and the content of each sample was expressed as mg per gram of dry weight tissue. Dry weight was obtained by weighing the tissue after 24 h at 608 C.
Extraction and quantitation of haemoglobin from intestinal tissue
The concentration of haemoglobin was determined colorimetrically by the cyanomethaemoglobin method 28 using reagents from Sigma, according to the modi cations carried out by Tavares de Lima et al. 29 Brie y, fragments of the ileal-jejunal portions of the small intestine were excised and minced in 2 ml of potassium cyanide and hexacyanoferrate solution. After 24 h at room temperature in the dark, the tissue was removed, the sample was centrifuged and the optical density of the supernatant was determined spectrophotometrically at 546 nm. The concentration of haemoglobin was calculated by comparison with a standard curve and was expressed as mg per gram of dry weight tissue. There is no signi cant interference of EB in this colorimetric assay, making both assays in samples from the same animal possible.
Assay of histamine released after antigen challenge
Histamine was measured in plasma by a modi cation of the method of Shore et al. 30 Brie y, blood was taken from a femoral artery cannulated with a polyethylene catheter, anticoagulated with edetic acid (EDTA), cooled at 48 C and centrifuged to remove cells. Histamine was extracted from 200 ml plasma samples by 0.4 N perchloric acid treatment, followed by sequential extractions in butanol and heptane. The uorometric assay was carried out after condensation of histamine with o-phthalaldehyde at alkaline pH. The uorescent product was measured at room temperature with wavelength excitation at 360 nm and emission at 450 nm. The concentration of histamine was determined from a standard curve constructed with known concentrations of histamine. For these experiments, the animals were anaesthetized with pentobarbital sodium (60 mg kg body weight), and a tracheostomy was then performed to facilitate breathing.
Statistical analyses
Data are expressed as the mean SEM. For comparison of two groups of samples normally distributed, the Student's two-tailed t-test was used to analyse differences for signi cance. For comparison of two groups of samples not normally distributed, the Mann-Whitney U-test was used. Statistical procedures were performed using a data base and statistical package (Instat, GraphPAD Software Inc., San Diego, CA), P , 0 05 was considered signi cant.
Results
Anaphylactic challenge triggers NO production by peritoneal adherent cells and modi® es their response to agonists
Adherent cells collected after induction of anaphylaxis spontaneously produced increased amounts of nitrite compared with cells from animals treated with either antigen or antibody alone (Fig. 1) . This production was suppressed by the speci c NO synthase inhibitor L-NMA, but not by D-NMA suggesting the involvement of the L-arginine pathway in the production of NO under these conditions. The time elapsed after anaphylaxis in uenced the ability of adherent peritoneal cells to produce NO, since maximal production was observed in cells collected 24 h after anaphylaxis (Fig. 1) . Further approaches to analyse the mechanism of the enhanced production of NO was carried out by examining the response of adherent peritoneal cells to a set of agonists that are either released after anaphylactic challenge or act through wellknown signalling pathways. As shown in Fig. 2 , the pattern of response to these agonists presented signi cant differences that can be summarized as follows. PMA was the only agonist that elicited an enhanced nitrite production in cells collected 10 min after anaphylaxis compared with controls. The response to IL-1b, IgE DNP complexes and PAF was reduced compared with controls, except in cells taken 24 h after challenge. LPS and dibutyryl cyclic adenosine monophosphate (AMP) elicited on cells from DNP-challenged animals a response similar to that observed in control rats, except when the cells were collected 24 hours after anaphylaxis, on which they elicited an increased production of nitrate. TNF-a at concentrations up to 1 nM did not induce signi cant NO production.
Treatment with SNP and SNAP prior to the anaphylactic reaction decreases haemorrhagic necrosis of the small intestine Attempts to delineate the effect of NO on rat anaphylaxis were performed with SNP and SNAP, two NO-generating compounds that are not structurally related. Treatment with SNP at the dose of 0.1 mg kg, i.p., prior to anaphylactic challenge, induced a signi cant reduction of the haemorrhagic necrosis without affecting extravasation signi cantly as judged from the accumulation of EB (Fig. 3) . A similar effect was observed with SNAP at the dose of 1 mg kg i.p. prior to the challenge with DNP-BSA. A group of rats treated with 1.4 mg kg of N-acetylpenicillamine showed no protection at all, which indicates that the effect of SNAP should be attributed to its nitrosyl moiety. Inhibition of NO synthesis with L-NMA at the dose of 10 mg kg did not elicit signi cant changes on the haemorrhagic necrosis, suggesting that the amount of NO that can be produced early after anaphylactic challenge from the constitutive isoform of NO synthase does not attain a suitable concentration to prevent injury. Treatment with SNAP does not affect the levels of plasma histamine after anaphylactic challenge
In order to obtain some information about the level at which the protective effect of SNAP on the anaphylactic reaction was exerted, histamine plasma levels were assayed at different times after DNP-BSA challenge as an indicator of mast cell activation and degranulation. Injection of DNP-BSA to sensitized rats produced a rapid increase of plasma histamine levels from 0 028 0 007 mM to 0 8 0 24 mM 5 min after challenge. This was followed by a decline of plasma histamine after 10 min. Assay of histamine plasma levels in rats pretreated with SNAP at both the usual dose of 1 mg kg (Fig. 4) and at 4 mg kg (not shown) did not induce any signi cant decrease of plasma histamine levels.
Discussion
In previous studies we have observed that triggering of anaphylactic reactions in rats passively sensitized with monoclonal antibody produces shock, extravasation of protein rich plasma, and severe lesions of the small intestine characterized by coagulative necrosis of the epithelial layer, oedema in the l amin a propri a, and extravasation of blood red cells into the interstitium. 4, 5 These changes are due to the triggering of the cascade of chemical mediators released from mast cells, and are analogous to those produced by the infusion of PAF. 2, 31 In the present study we show that triggering of the anaphylactic reaction also induces NO production by adherent peritoneal cells and modi es the response of these cells to NO-inducers. This seems to be due to the sudden release of a variety of autacoids that initiate chemical signalling. Analysis of the different molecules that could be implicated in this signalling should include products derived from mast cells as well as direct activation of macrophages by IgEantigen complexes via the low af nity FceRII CD23 receptor. Activation of NO production through this receptor seems to be of potential importance since it is involved in parasite killings. 20 Among the list of mast-cell derived products that could induce NO production on macrophages we focused on PAF, IL-1b, and TNF-a, based on their well-documented ability to induce NO production. 18, 32, 33 On the other hand, to address the chance of a direct triggering of macrophages via CD23 antigen we have utilized preformed IgE-DNP complexes. In addition, we selected other agonists in view of their unique properties of inducing NO synthase by well-known biochemical pathways. Thus, LPS was used as a good reference compound that is currently used to induce NO production. Dibutyryl cyclic AMP was selected in view of its well-known effect on mesangial cells, macrophages and smooth muscle vascular cells by a mechanism different from that involved in NO induction by IL-1b. 34 PMA was used as an 
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inductor of NO production by protein kinase Cdependent mechanisms. 35 Analysis of the responses to these agonists after anaphylaxis showed down-regulation of the responses to some of them, namely IL-1b, PAF and IgE DNP complexes, suggesting that cells could have reacted with these stimuli prior to ex vivo stimulation, this event leading to a cross-talk of signals. This is in keeping with what could be expected on the basis of the autacoids that are released after IgE challenge, and could explain the up-regulation of NO production observed in cells removed after anaphylaxis. In keeping with this interpretation, an increased concentration of NO has been detected in the exhaled air of patients after allergen-induced late asthmatic reactions, 36 and this has been considered a good indicator of the degree of in ammation of the airways. This also agrees with the enhanced production of NO by peritoneal cells taken after the induction of immune-complex peritonitis. 17 To de ne the pathophysiological consequences of the modulation of NO production during anaphylaxis we rst carried out experiments with L-NMA to inhibit NO production. This treatment did not modify the extent of both haemorrhagia and extravasation in animals undergoing anaphylactic challenge. This is different from the reported increase of epithelial permeability produced by inhibition of NO synthase via activation of mucosal mast cells, which has been associated with the release of PAF, histamine and superoxide. 37 A likely explanation could be the time-frame in which these changes occur, since in that report they were maximal 30 min after treatment with the NO synthase inhibitor. Another reason could be that NO synthase inhibition on its own initiates the generation of mediators by mast cells and, thereby, enhances the release of chemical mediators triggered by anaphylaxis. Since the magnitude of tissue injury is very prominent in our model, it seems dif cult to enhance damage by pharmacological procedures.
On the other hand, treatment with two structurally unrelated NO-generating compounds showed a signi cant protection of the haemorrhagic component of the lesions without reducing protein-rich plasma extravasation. It is not fully unexpected that haemorrhagia and exudation show different pharmacological modulation. A likely explanation for this nding is that the occurrence of haemorrhagia might require a wide disruption of the integrity of endothelial cells, compared with the mild changes needed for protein-rich plasma extravasation to occur. This agrees with the results we observed antagonizing the PAF receptor. 5 Since a portion of the effect of NO on gastrointestinal mucosal defence has been associated to its role as an endogenous modulator of mast cell reactivity, 16, 38 we measured plasma histamine after anaphylactic challenge as a reporter of mast cell activation. Plasma histamine concentrations in SNAP-treated animals were not signi cantly different from those measured in non-treated animals after antigen challenge, making it unlikely that the alleviation of intestinal haemorrhagia produced by NOgenerating compounds could only be explained by an overall inhibition of mast cell activation. 39 In fact, the assay of plasma histamine is only an indicator of mast cell activation, whereas other mediators, e.g. PAF, seem to be the actual effectors of the injury. 5 However, the recent report of the blockade of PAF-induced bowel injury by NO-donors 40 strongly suggests that these compounds operate downstream the mast cell activation step.
Potential targets of NO are redox-sensitive signalling pathways which include protein tyrosine phosphatases and kinases that are affected by covalent interactions with sulphydryl groups. 41, 42 This seems of interest because protein tyrosine phosphorylation reactions are involved in biochemical signalling in the microcirculation. 43 NO also has effects on the transcription factor NF-kB. This action is linked to the ability of NO to scavenge and inactivate superoxide anion, 44 and might be of central importance in vascular biology because NF-kB is involved in endothelial cell activation by promoting the expression of adhesion molecules and proin ammatory cytokines. 13, 14 Transcriptional activation of the p50 subunit of NF-kB has been demonstrated in the small bowel of mice treated with either PAF or TNF-a at concentrations lower than those required to produce systemic changes. 45 Therefore, the effect of NO-generating compounds in the attenuation of the haemorrhagic necrosis associated with IgE-dependent mast cell activation should be related to these types of interactions rather than to the inhibition of the release of mediators from mast cells.
